In a large trial that compared RP with exclusive radiotherapy in 1682 men with PCa, the strongest predictive factors of a biochemical relapse were the pretherapeutic PSA value, the Gleason score on biopsy, the clinical T-stage and the radiation dose for patients who underwent radiation therapy [11]. The gene discussed is KLK3; the disease is posterior cortical atrophy.